E-LIB Suche - Ergebnisse für: Mosele, F.

1

Moving toward precision medicine to predict drug sensitivit..:

Bottosso, M. ; Mosele, F. ; Michiels, S....
ESMO Open. 9 (2024) 3 - p. 102247 , 2024

Link: https://doi.org/10.1016/..

2

Precision medicine in the era of multi-omics: can the data ..:

Aldea, M. ; Friboulet, L. ; Apcher, S....
ESMO Open. 8 (2023) 5 - p. 101642 , 2023

Link: https://doi.org/10.1016/..

3

Trastuzumab deruxtecan for breast cancer: do patients exper..:

Mosele, F. ; Di Maio, M.
Annals of Oncology. 34 (2023) 7 - p. 567-568 , 2023

Link: https://doi.org/10.1016/..

4

Redox and metabolic strategies developed by anterior and po..:

Fernandes, F.A. ; Dutra, B.K. ; Mosele, F....
Science of The Total Environment. 639 (2018) - p. 457-464 , 2018

Link: https://doi.org/10.1016/..

5

Innovative Clay Unit Reinforced Masonry System: Testing, De..:

Mosele, F. ; Da Porto, F.
Procedia Engineering. 14 (2011) - p. 2109-2116 , 2011

Link: https://doi.org/10.1016/..

6

Recommendations for the use of next-generation sequencing (..:

Mosele, M.F. ; Westphalen, C.B. ; Stenzinger, A....
Annals of Oncology. 35 (2024) 7 - p. 588-606 , 2024

Link: https://doi.org/10.1016/..

7

7P Trastuzumab deruxtecan (T-DXd) for advanced breast cance..:

Dieras, V.C. ; André, F. ; Lusque, A....
ESMO Open. 9 (2024) - p. 103016 , 2024

Link: https://doi.org/10.1016/..

8

52P Comparing the genomic landscape of de novo vs recurrent..:

Giugliano, F. ; Douglas, J.R. Dixon ; Dien, A. Tran...
ESMO Open. 9 (2024) - p. 103059 , 2024

Link: https://doi.org/10.1016/..

9

29P Prevalence of high tumor mutational burden (TMB) in pat..:

Ribeiro, J.T.M.L.M. ; Dien, A. Tran ; Mignot, L....
ESMO Open. 8 (2023) 1 - p. 101253 , 2023

Link: https://doi.org/10.1016/..

10

189O A phase II study of patritumab deruxtecan (HER3-DXd), ..:

Pistilli, B. ; Ibrahimi, N. ; Lacroix-Triki, M....
ESMO Open. 8 (2023) 1 - p. 101378 , 2023

Link: https://doi.org/10.1016/..

11

HSD19 Evaluation of Vascular Access Modality for Hemodialys..:

Monteverde Spencer, G.T. ; Dovizio, M. ; Iacolare, B....
Value in Health. 26 (2023) 12 - p. S297-S298 , 2023

Link: https://doi.org/10.1016/..

12

HSD16 PCSK-9 Inhibitors for the Control of Hypercholesterol..:

Perrone, V ; Iacolare, B ; Dovizio, M...
Value in Health. 25 (2022) 12 - p. S275-S276 , 2022

Link: https://doi.org/10.1016/..

13

CO61 Clinical Profile and Healthcare Resource Use of ANCA-A..:

Perrone, V ; Dovizio, M ; Veronesi, C...
Value in Health. 25 (2022) 12 - p. S29 , 2022

Link: https://doi.org/10.1016/..

14

HSD64 Drug Discontinuation and Healthcare Cost Evaluation i..:

Perrone, V ; Secchi, O ; Serra, A...
Value in Health. 25 (2022) 12 - p. S286 , 2022

Link: https://doi.org/10.1016/..

15

HSD61 Trends in Discontinuation of Lipid-Lowering and Antih..:

Dovizio, M ; Perrone, V ; Iacolare, B...
Value in Health. 25 (2022) 12 - p. S285 , 2022

Link: https://doi.org/10.1016/..